Benzodiazepine and Metabolite Confirmation (Labcorp MedWatch®)
Use
Drug analysis/clinical drug monitoring
Special Instructions
This profile is intended for pain management purposes and is not suitable for workplace testing. It does not comply with state regulatory workplace testing programs, emphasizing its specific applicability to clinical settings rather than employment-related drug screening.
Limitations
The test results should be interpreted in the context of clinical information, as patient metabolic variables and specific drug chemistries can impact outcomes. Specimen characteristics should also be considered, and technical consultation is recommended if results are inconsistent with clinical expectations. This test does not encompass all possible drugs and may require further confirmatory testing depending on initial findings.
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 53745-6
- 3390-2
- 3861-2
- 16228-9
- 12361-2
- 16201-6
- 3654-1
- 16231-3
- 18187-5
- 17088-6
- 9351-8
- 59615-5
- 19245-0
- 16229-7
- 16206-5
- 20559-1
- 14192-9
- 16232-1
- 19586-7
- 16233-9
- 77202-0
Result Turnaround Time
4-5 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
20 mL
Minimum Volume
Not provided
Container
Plastic urine container
Storage Instructions
Maintain specimen at room temperature.
Causes for Rejection
Quantity not sufficient for analysis; incorrect specimen
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |